PURE
PURE BIOSCIENCE
stockOTC
pure bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges. pure's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate (sdc)- based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. patented sdc is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. as a platform technology, sdc is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. pure is headquartered in el cajon, california (san diego metropolitan area). additional information on pure is available at www.purebio.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.06 | 2026-09-28 | -2.36% | -18.288 |
| 1M | 0.07 | 2026-09-04 | -4.46% | -9.667 |
| 3M | 0.07 | 2026-07-06 | -10.90% | -4.556 |
| 6M | 0.09 | 2026-04-06 | -32.37% | -1.653 |
| 1Y | 0.09 | 2025-10-03 | -34.18% | -1.073 |
| 2Y | 0.07 | 2024-10-04 | -11.58% | — |
| 5Y | 0.39 | 2021-10-04 | -84.14% | -0.071 |
PURE BIOSCIENCE (OTC:PURE) stock price today is $0.06, and today's volume is 14,303. PURE is down 8.542% today. The 30 day average volume is 36,911. PURE market cap is $6.95M with 111.86M shares outstanding.